Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      ERT Reports Fourth Quarter and Full Year 2011 Operating Results

      -- Record revenues of $52.3 million for the fourth quarter and $184.9 million for the full year 2011

      -- GAAP diluted net income per share of $0.09 for the fourth quarter / Non-GAAP diluted net income per share of $0.14 for the fourth quarter

      -- Record bookings of $82.5 million for the fourth quarter / $303.5 million for full year 2011

      -- 2012 guidance for revenue of $195 to $203 million / GAAP diluted net income per share of between $0.40 and $0.48 / Non-GAAP diluted net income per share of between $0.45 and $0.53


      News provided by

      ERT

      Feb 27, 2012, 04:05 ET

      Share this article

      Share this article


      PHILADELPHIA, Feb. 27, 2012/PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of health outcomes research services and customizable medical devices to biopharmaceutical sponsors and contract research organizations (CROs),announced results today for the fourth quarter and fiscal year ended December 31, 2011.  Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.  The financial results for 2010 include the seven months' results related to the acquisition of CareFusion Research Services (RS or German operations) that was completed on May 28, 2010.

      This press release contains financial measures prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and non-GAAP measures adjusted to exclude the impact of the amortization of the acquired intangibles and other assets, acquisition and other costs related to the RS acquisition, an investment impairment and related income tax effects.  A reconciliation of these GAAP and non-GAAP measures is found in the attached "Reconciliation of GAAP to Non-GAAP Information."

      Financial Highlights for the Fourth Quarter of 2011

      • Net revenues were $52.3 million for the fourth quarter of 2011 compared to $48.1 million for the third quarter of 2011 and $44.9 million a year ago.  
      • GAAP gross margin percentage was 40.9% in the fourth quarter of 2011 compared to 41.5% for the third quarter of 2011 and 43.9% a year ago.  Non-GAAP gross margin percentage was 44.9% in the fourth quarter of 2011 compared to 45.5% for the third quarter of 2011 and 49.0% a year ago.  The GAAP and Non-GAAP gross margin percentage decline year over year was due to higher costs associated with the ramp up of our German operations to meet customer study deliverables, integration related activities and additions to inventory reserves.  
      • GAAP operating income margin percentage was 12.1% in the fourth quarter of 2011 compared to 10.9% for the third quarter of 2011 and 11.6% a year ago.  Non-GAAP operating income margin percentage was 16.2% in the fourth quarter of 2011 compared to 14.9% for the third quarter of 2011 and 18.5% a year ago.
      • GAAP net income was $4.5 million, or $0.09 per diluted share, in the fourth quarter of 2011 compared to $4.3 million, or $0.09 per diluted share, in the third quarter of 2011 and $4.1 million, or $0.08 per diluted share, a year ago.  Impacting GAAP net income is a $0.7 million charge recorded in other expense, net for an investment impairment of marketable securities that we received in connection with the sale of our former EDC operations in 2009.  Non-GAAP net income was $6.9 million, or $0.14 per diluted share, in the fourth quarter of 2011 compared to $5.6 million, or $0.11 per diluted share, in the third quarter of 2011 and $6.1 million, or $0.12 per diluted share, a year ago.  
      • Cash flow from operations was $19.5 million in the fourth quarter of 2011, compared to $9.2 million in the third quarter of 2011 and $17.1 million a year ago.
      • Cash and short-term investments totaled $39.0 million at December 31, 2011 compared to $30.4 million at December 31, 2010.  
      • New bookings were $82.5 million in the fourth quarter of 2011 compared to $78.4 million for the third quarter of 2011 and $58.9 million a year ago.  
      • The gross book-to-bill ratio was 1.6 in the fourth quarter of 2011 compared to 1.6 in the third quarter of 2011 and 1.3 a year ago.  
      • Backlog was $357.4 million at December 31, 2011 compared to $343.8 million at September 30, 2011 and $302.9 million at December 31, 2010.  The annualized cancellation rate was 16.8% in the fourth quarter of 2011 compared to 14.6% in the third quarter of 2011 and 16.6% a year ago.  

      Financial highlights for the full year of 2011

      • Net revenues were $184.9 million for the year ended December 31, 2011 compared to $141.0 million for the year ended December 31, 2010.  Revenues from our German operations were $87.9 million for the year ended December 31, 2011 and $47.2 million from the date of acquisition to December 31, 2010.
      • GAAP gross margin percentage was 41.0% for the year ended December 31, 2011 compared to 47.8% for the year ended December 31, 2010.  Non-GAAP gross margin percentage was 45.2% for the year ended December 31, 2011 compared to 51.7% for the year ended December 31, 2010.  
      • GAAP operating income margin percentage was 10.5% for the year ended December 31, 2011 compared to 11.1 % for the year ended December 31, 2010.  Non-GAAP operating income margin percentage was 14.8% for the year ended December 31, 2011 compared to 19.2% for the year ended December 31, 2010.
      • GAAP net income was $13.7 million, or $0.28 per diluted share, for the year ended December 31, 2011 compared to $9.9 million, or $0.20 per diluted share, for the year ended December 31, 2010.  Non-GAAP net income was $20.0 million, or $0.41 per diluted share, for the year ended December 31, 2011 compared to $18.4 million, or $0.37 per diluted share, for the year ended December 31, 2010.  
      • Cash flow from operations was $42.5 million for the year ended December 31, 2011 compared to $35.9 million for the year ended December 31, 2010.  
      • New bookings were $303.5 million for the year ended December 31, 2011 compared to $212.2 million for the year ended December 31, 2010.  

      "We are pleased with the Company's results, which include record revenues and bookings for the fourth quarter and full year," commented Dr. Jeffrey Litwin, President and CEO of ERT.  "This is the first quarter our bookings have ever exceeded $80 million and it marks the fourth consecutive quarter of more than $70 million in bookings.  Bookings growth was driven by sustained strength in both our cardiac safety and respiratory solutions.  Our continued growth shows that our message, outlining the benefits of centralization, along with the ability to purchase high quality cardiac safety, respiratory and ePRO services from one vendor is resonating with our clients."  

      "We enter 2012, having completed the integration of our German operations and we launched our next generation platform, EXPERT 3 in January 2012," continued Dr. Litwin.  "EXPERT 3 unifies our core offerings onto a single software platform with a unified portal technology. It provides meaningful increases in capacity and should drive efficiencies while providing additional value to our clients as we progress through 2012. We also launched Master Scope 32, our new laptop based platform for use at our investigator sites in support of all of our business lines."

      2012 Guidance

      The Company issued guidance for the full year of 2012.  ERT expects net revenues of between $195 million and $203 million for 2012.  ERT expects GAAP diluted net income per share to be between $0.40 and $0.48 for 2012 and non-GAAP diluted net income per share to be between $0.45 and $0.53 for the same period.  

      For the first quarter ending March 31, 2012, ERT expects net revenues of between $46 million and $49 million, GAAP diluted net income per share to be between $0.07 and $0.10 and non-GAAP diluted net income per share to be between $0.08 and $0.11.  

      Use of Non-GAAP Financial Measures

      In addition to GAAP financial measures, ERT uses certain non-GAAP financial measures that exclude charges related to the amortization of the RS acquired intangible and other assets and acquisition and other costs which are related to the RS acquisition and in 2011 an other-than-temporary impairment of marketable securities that we received in connection with the sale of our former EDC operations in 2009, and also their related income tax effects.  ERT believes that these non-GAAP measures are useful to investors because this supplemental information facilitates comparisons of its operations from period to period and to the performance of other companies within its industry and assists in gaining a better understanding of its operating results and future prospects.  ERT views amortization of acquired intangible and other assets related to the RS acquisition, which includes such items as the amortization of acquired customer backlog and technology, as items determined at the time of the acquisition.  While ERT reviews the underlying value of these intangibles regularly for impairment, the amortization is an expense typically not affected by operations during any particular period and does not contribute to the operational performance in any particular period.  ERT regards acquisition and other costs related to its recent acquisition and the other-than-temporary impairment charge as costs that do not recur on a regular basis.

      ERT's non-GAAP effective tax rates differ from its GAAP effective tax rates for 2011 because of 1) the exclusion of the amortization of acquired intangible and other assets and acquisition and other costs related to its recent acquisition of RS, and 2) the income tax effect due to the difference between the GAAP and non-GAAP effective tax rate applied against the GAAP pre-tax income, primarily as a result of the acquisition costs and the other-than-temporary impairment charge  not being deductible for income tax purposes.  ERT excludes the impact of these discrete tax items from its non-GAAP income tax provision because it believes they are not indicative of the effective income tax rate of its ongoing business operations.

      Management uses these non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring ERT's operating performance, financial and operating decision-making, development of budgets and comparing such performance to that of prior periods for the same reasons stated above.  These non-GAAP financial measures are not meant to be considered superior to or a substitute for comparable financial measures prepared in accordance with GAAP.  There are also limitations on the non-GAAP measures, including: 1) these non-GAAP measures do not have standardized meanings and may not be comparable to similar non-GAAP measures used by other companies, 2) acquisition and other costs related to ERT's recent acquisition of RS represent actual cash expenditures that are excluded from ERT's non-GAAP measures, and 3) although amortization of acquired intangible and other assets does not directly impact ERT's current cash position, such expense is amortized over their expected economic lives and does represent the declining value of the assets acquired, but this expense is excluded from ERT's non-GAAP measures.  ERT adjusts for these limitations by relying on these non-GAAP measures only as a supplement to its GAAP results.

      Conference Call

      Dr. Litwin, the Company's President and CEO, and Mr. Keith Schneck, the Company's Chief Financial Officer, will hold a conference call to discuss these results.  The conference call will take place at 5:00 PM EST on February 27, 2012.  For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally.  There will be a playback available as well.  To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 10010375.  This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com.  The webcast may also be accessed via the link at http://www.videonewswire.com/event.asp?id=85360.

      The webcast can be accessed for up to one year on either site.  

      About eResearchTechnology, Inc.

      ERT (www.ert.com) is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations (CROs) to achieve their drug development and healthcare objectives.  ERT harnesses leading technology coupled with unrivaled processes and scientific expertise to collect, analyze, and report on clinical data to support the determination of health outcomes critical to the approval, labeling and reimbursement of pharmaceutical products.  ERT is the acknowledged industry leader in centralized cardiac safety and respiratory efficacy services and also provides electronic Patient Reported Outcomes (ePRO) and outcomes assessments for multiple modalities across all phases.

      This release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to our operations.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  They use words such as "aim," "anticipate," "are confident," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "look to" and other words and terms of similar meaning in conjunction with a discussion of future operating or financial performance.  

      These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Factors that might cause such a difference include: unfavorable economic conditions; our ability to obtain new contracts and accurately estimate net revenues, our positive outlook for future bookings, variability in size, scope and duration of projects and internal issues at the sponsoring client; our ability to successfully integrate any future acquisitions; competitive factors in the market for our centralized services; changes in the bio-pharmaceutical and healthcare industries to which we sell our solutions; technological development; and market demand.  There is no guarantee that the amounts in our backlog will ever convert to revenue.  Should the economic conditions deteriorate the cancellation rates that we have historically experienced could increase.  Further information on potential factors that could affect the Company's financial results can be found in ERT's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  Guidance is based on management's good faith expectations given current market conditions but that continued or further deterioration of general economic conditions, in addition to other factors cited elsewhere, could result in ERT not achieving the revenue and net income per diluted share guidance provided.

      Forward-looking statements speak only as of the date made.  We undertake no obligation to update any forward-looking statements, including prior forward-looking statements, to reflect the events or circumstances arising after the date as of which they were made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this release or that may be made in our filings with the Securities and Exchange Commission or elsewhere from time to time by, or on behalf of, us.

      Contact:

      Keith Schneck    

      Robert East

      eResearchTechnology, Inc.  

      Westwicke Partners, LLC

      215-282-5566

      410-312-0502



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Operations

      (in thousands, except per share amounts)

      (unaudited)







      Three Months Ended December 31,


      Year Ended December 31,


      2010


      2011


      2010


      2011







      Net revenues:









      Services

      $          26,257


      $          27,703


      $          85,718


      $         99,289


      Site support

      18,643


      24,588


      55,274


      85,633









      Total net revenues

      44,900


      52,291


      140,992


      184,922









      Costs of revenues:









      Cost of services

      14,241


      14,738


      43,403


      56,063


      Cost of site support

      10,951


      16,170


      30,212


      53,056









      Total costs of revenues

      25,192


      30,908


      73,615


      109,119









      Gross margin

      19,708


      21,383


      67,377


      75,803









      Operating expenses:









      Selling and marketing

      4,237


      4,604


      16,064


      17,888


      General and administrative

      8,329


      8,115


      30,607


      31,011


      Research and development

      1,912


      2,314


      5,089


      7,397









      Total operating expenses

      14,478


      15,033


      51,760


      56,296









      Operating income

      5,230


      6,350


      15,617


      19,507

      Foreign exchange gains (losses)

      311


      751


      (956)


      171

      Other expense, net

      (58)


      (862)


      (239)


      (1,256)









      Income before income taxes

      5,483


      6,239


      14,422


      18,422

      Income tax provision

      1,363


      1,712


      4,551


      4,694









      Net income

      $            4,120


      $            4,527


      $            9,871


      $         13,728









      Net income per share:









      Basic

      $              0.08


      $              0.09


      $              0.20


      $             0.28


      Diluted

      $              0.08


      $              0.09


      $              0.20


      $             0.28









      Shares used in computing net income per share:









      Basic

      48,867


      49,241


      48,808


      49,129


      Diluted

      49,274


      49,265


      49,190


      49,289



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Balance Sheets

      (in thousands, except share and per share amounts)

      (unaudited)










      December 31, 2010


      December 31, 2011

      ASSETS








      Current assets:




          Cash and cash equivalents

      $                                    30,343


      $                        38,928

          Short-term investments

      50


      50

          Investment in marketable securities

      648


      405

          Accounts receivable less allowance for doubtful accounts




               of $515 and $207, respectively

      37,236


      41,617

          Inventory

      4,698


      8,863

          Prepaid income taxes

      1,988


      4,451

          Prepaid expenses and other

      4,393


      4,270

          Deferred income taxes

      3,431


      3,605

              Total current assets

      82,787


      102,189





      Property and equipment, net

      42,615


      53,272

      Goodwill

      71,637


      72,915

      Intangible assets

      17,187


      10,711

      Deferred income taxes

      -


      724

      Other assets

      609


      557





                 Total assets

      $                                  214,835


      $                      240,368





      LIABILITIES AND STOCKHOLDERS' EQUITY








      Current liabilities:




          Accounts payable

      $                                      7,136


      $                          7,412

          Accrued expenses

      16,162


      16,230

          Income taxes payable

      -


      986

          Deferred revenues

      11,670


      13,544

              Total current liabilities

      34,968


      38,172





      Deferred rent

      2,368


      2,411

      Deferred income taxes

      3,703


      7,946

      Long-term debt

      21,000


      21,000

      Other liabilities

      2,141


      1,162





                 Total liabilities

      64,180


      70,691





      Stockholders' equity:




          Preferred stock-$10.00 par value, 500,000 shares authorized,




               none issued and outstanding

      -


      -

          Common stock-$.01 par value, 175,000,000 shares authorized,




               60,460,782 and 60,838,449 shares issued, respectively

      605


      608

          Additional paid-in capital

      100,441


      104,189

          Accumulated other comprehensive (loss) income

      (1,545)


      44

          Retained earnings

      131,037


      144,765

          Treasury stock, 11,589,603 and 11,596,966 shares at cost,




               respectively

      (79,883)


      (79,929)





              Total stockholders' equity

      150,655


      169,677





                 Total liabilities and stockholders' equity

      $                                  214,835


      $                      240,368



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Cash Flows

      (in thousands)

      (unaudited)



      Year Ended December 31,


      2010


      2011





      Operating activities:




        Net income

      $   9,871


      $    13,728

        Adjustments to reconcile net income to net cash




            provided by operating activities:




                Depreciation and amortization

      19,751


      26,192

                Cost of sales of equipment

      1,158


      21

                Share-based compensation

      2,717


      2,989

                Deferred income taxes

      (651)


      3,394

                Investment impairment charge

      -


      749

                Loss on disposal of equipment

      -


      1,686

                Changes in operating assets and liabilities:




                   Accounts receivable

      (7,091)


      (4,458)

                   Inventory

      (1,265)


      (1,854)

                   Prepaid expenses and other

      476


      (799)

                   Accounts payable

      4,131


      (144)

                   Accrued expenses

      8,054


      561

                   Income taxes

      (687)


      (1,503)

                   Deferred revenues

      (358)


      1,889

                   Deferred rent

      (179)


      37

                       Net cash provided by operating activities

      35,927


      42,488





      Investing activities:




        Purchases of property and equipment

      (21,746)


      (33,701)

        Purchases of investments

      (999)


      -

        Proceeds from sales of investments

      10,731


      -

        Payments for acquisitions

      (82,789)


      (117)

                       Net cash used in investing activities

      (94,803)


      (33,818)





      Financing activities:




        Proceeds from long-term debt

      23,000


      -

        Repayment of long-term debt

      (2,000)


      -

        Proceeds from exercise of stock options

      229


      774

        Stock option income tax impact

      55


      (78)

        Repurchase of common stock for treasury

      -


      (46)

                       Net cash provided by financing activities

      21,284


      650





      Effect of exchange rate changes on cash

      (1,044)


      (735)





      Net (decrease) increase in cash and cash equivalents

      (38,636)


      8,585

      Cash and cash equivalents, beginning of period

      68,979


      30,343





      Cash and cash equivalents, end of period

      $ 30,343


      $    38,928



      eResearchTechnology, Inc. and Subsidiaries

      Reconciliation of GAAP to Non-GAAP Information

      (in thousands, except per share amounts)

      (unaudited)








      Three Months Ended


      Year Ended








      December 31,
      2010

      September 30,
      2011

      December 31,
      2011


      December 31,
      2010


      December 31,
      2011

      Net revenues


      $        44,900

      $         48,083

      $        52,291


      $      140,992


      $      184,922










      Reconciliation of GAAP to Non-GAAP gross margin:









      GAAP gross margin


      $        19,708

      $         19,955

      $        21,383


      $        67,377


      $        75,803

      Amortization of acquired intangibles and other assets


      2,288

      1,926

      1,832


      5,572


      7,606

      Acquisition and integration related costs


      -

      -

      259


      -


      259

      Non-GAAP gross margin


      $        21,996

      $         21,881

      $        23,474


      $        72,949


      $        83,668

      Non-GAAP gross margin percentage


      49.0%

      45.5%

      44.9%


      51.7%


      45.2%










      Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenues 










      Reconciliation of GAAP to Non-GAAP









          operating income:









      GAAP operating income


      $          5,230

      $           5,233

      $          6,350


      $        15,617


      $        19,507

      Amortization of acquired intangibles and other assets


      2,288

      1,926

      1,832


      5,572


      7,606

      Acquisition and integration related costs


      800

      -

      309


      5,939


      309

      Non-GAAP operating income


      $          8,318

      $           7,159

      $          8,491


      $        27,128


      $        27,422

      Non-GAAP operating income margin percentage


      18.5%

      14.9%

      16.2%


      19.2%


      14.8%










      Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenues 










      Reconciliation of GAAP to Non-GAAP net income:









      GAAP net income


      $          4,120

      $           4,327

      $          4,527


      $          9,871


      $        13,728

      Amortization of acquired intangibles and other assets


      2,288

      1,926

      1,832


      5,572


      7,606

      Acquisition and integration related costs


      800

      -

      309


      5,939


      309

      Investment impairment


      -

      -

      749


      -


      749

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate


      (1,123)

      (611)

      (551)


      (2,969)


      (2,417)

      Non-GAAP net income


      $          6,085

      $           5,642

      $          6,866


      $        18,413


      $        19,975



















      Reconciliation of GAAP to Non-GAAP diluted









          net income per share:









      GAAP diluted net income per share


      $            0.08

      $             0.09

      $            0.09


      $            0.20


      $            0.28

      Amortization of acquired intangibles and other assets


      0.05

      0.03

      0.03


      $            0.11


      0.15

      Acquisition and integration related costs


      0.01

      -

      0.01


      $            0.12


      0.01

      Investment impairment


      -

      -

      0.02


      -


      0.02

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate


      (0.02)

      (0.01)

      (0.01)


      $          (0.06)


      (0.05)

      Non-GAAP diluted net income per share


      $            0.12

      $             0.11

      $            0.14


      $            0.37


      $            0.41










      Shares used in computing diluted net income per share


      49,274

      49,311

      49,265


      49,190


      49,289

      Assumed effective tax rate - Non-GAAP


      29.0%

      27.0%

      27.0%


      29.0%


      27.0%






























      Three Months


      Year



      Ending March 31, 2012


      Ending December 31, 2012












      Low Range


      High Range


      Low Range


      High Range

      Reconciliation of GAAP to Non-GAAP









          diluted net income per share guidance:









      GAAP estimate of diluted net income per share


      $            0.07


      $            0.10


      $            0.40


      $            0.48

      Estimated effect on diluted net income per share of:









          Amortization of acquired intangibles and other assets


      0.02


      0.02


      0.07


      0.07

          Income tax effect due to Non-GAAP reconciling items
               and other differences between the GAAP and
               Non-GAAP effective tax rate


      (0.01)


      (0.01)


      (0.02)


      (0.02)

      Non-GAAP estimate of diluted net income per share


      $            0.08


      $            0.11


      $            0.45


      $            0.53



      SOURCE ERT

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.